IPO - Profile

Ortho Clinical Diagnostics Holdings plc

Health Care > Biotechnology: In Vitro & In Vivo Diagnostic Substances



We are a pure-play IVD business driven by our credo, “Because Every Test is A Life.” This guiding principle reflects the crucial role diagnostics play in global health and guides our priorities as an organization. As a leader in IVD, we impact approximately 800,000 patients every day. We are dedicated to improving outcomes for these patients and saving lives through providing innovative and reliable diagnostic testing solutions to the clinical laboratory and transfusion medicine communities. Our global infrastructure and commercial reach allow us to serve these markets with significant scale. More

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$17.00 76,000,000 Positive High 19.85%

Offering Team

  • Legal counsel
  • Latham & Watkins LLP
  • Auditors
  • PricewaterhouseCoopers LLP

Deal Highlights

Deal Tracker

IPO Dates

Filing 27 Jan, 2021

Offer 28 Jan, 2021

Look Ahead

Lock Up Expiry Jul 28, 2021

IPO Terms

Offer Price $17.00
Offer Size 76M

Market Sentiments

Stock Price